Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 6/20 | 0.34 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.31 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.31 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26401320 | 0.90 | ACACB (0.35) | CNR2CACNA1GCACNA1HKCNH2CACNA1I | |
| SCHEMBL22932412 | 0.82 | BACE1 (0.40) | BACE1CNR2CNR1USP2MAPT | |
| SCHEMBL21182256 | 0.74 | BACE1 (0.41) | BACE1CNR2CNR1USP2MAPT | |
| SCHEMBL17992230 | 0.74 | BACE1 (0.38) | BACE1CNR2CNR1USP2MAPT | |
| SCHEMBL19992569 | 0.74 | BACE1 (0.42) | BACE1CNR2CNR1USP2MAPT | |
| SCHEMBL19992568 | 0.73 | BACE1 (0.37) | BACE1CNR2CNR1USP2MAPT | |
| SCHEMBL1977314 | 0.72 | P4HTM (0.55) | BACE1MAPTTSHRP4HTM | |
| SCHEMBL17992211 | 0.72 | BACE1 (0.37) | BACE1CNR2USP2MAPTTSHR | |
| SCHEMBL26401362 | 0.72 | ACACB (0.37) | BACE1CNR2CACNA1GCACNA1HKCNH2 | |
| SCHEMBL15670153 | 0.72 | CYP1A2 (0.42) | BACE1CNR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779018-B2 | Heterocyclic compound and arthropod pest control composition containing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-10 | — | — | US | disclosed |
| US-20210030003-A1 | HETEROCYCLIC COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210030003-A1 | HETEROCYCLIC COMPOUND AND ARTHROPOD PEST CONTROL COMPOSITION CONTAINING SAME | C5, PRXL2A, NOX3 | BACE1 3014/4885CNR2 612/4885CNR1 716/4885 |
| US-11779018-B2 | Heterocyclic compound and arthropod pest control composition containing same | C5, PRXL2A, NOX3 | BACE1 3014/4885CNR2 612/4885CNR1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.